227 related articles for article (PubMed ID: 12826992)
1. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A
J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
[TBL] [Abstract][Full Text] [Related]
2. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
Poyurovsky M; Pashinian A; Weizman R; Fuchs C; Weizman A
Biol Psychiatry; 2006 Jun; 59(11):1071-7. PubMed ID: 16497273
[TBL] [Abstract][Full Text] [Related]
3. Role of mirtazapine in the treatment of antipsychotic-induced akathisia.
Hieber R; Dellenbaugh T; Nelson LA
Ann Pharmacother; 2008 Jun; 42(6):841-6. PubMed ID: 18460588
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia.
Poyurovsky M; Bergman J; Pashinian A; Weizman A
Int Clin Psychopharmacol; 2014 Sep; 29(5):296-8. PubMed ID: 24667488
[TBL] [Abstract][Full Text] [Related]
5. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
6. Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study.
Miodownik C; Lerner V; Statsenko N; Dwolatzky T; Nemets B; Berzak E; Bergman J
Clin Neuropharmacol; 2006; 29(2):68-72. PubMed ID: 16614537
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study.
Baskak B; Atbasoglu EC; Ozguven HD; Saka MC; Gogus AK
J Clin Psychopharmacol; 2007 Jun; 27(3):289-94. PubMed ID: 17502777
[TBL] [Abstract][Full Text] [Related]
8. Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.
Lerner V; Bergman J; Statsenko N; Miodownik C
J Clin Psychiatry; 2004 Nov; 65(11):1550-4. PubMed ID: 15554771
[TBL] [Abstract][Full Text] [Related]
9. Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Avital A; Gross-Isseroff R; Stryjer R; Hermesh H; Weizman A; Shiloh R
Eur Neuropsychopharmacol; 2009 Jul; 19(7):476-82. PubMed ID: 19342206
[TBL] [Abstract][Full Text] [Related]
10. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
Berk M; Gama CS; Sundram S; Hustig H; Koopowitz L; D'Souza R; Malloy H; Rowland C; Monkhouse A; Monkhouse A; Bole F; Sathiyamoorthy S; Piskulic D; Dodd S
Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
[TBL] [Abstract][Full Text] [Related]
11. The effect of mirtazapine in patients with chronic pain and concomitant depression.
Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
[TBL] [Abstract][Full Text] [Related]
12. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.
Pahwa R; Lyons KE
Mov Disord; 2003 May; 18(5):584-7. PubMed ID: 12722174
[TBL] [Abstract][Full Text] [Related]
13. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
Ranjan S; Chandra PS; Chaturvedi SK; Prabhu SC; Gupta A
Ann Pharmacother; 2006 Apr; 40(4):771-4. PubMed ID: 16569791
[TBL] [Abstract][Full Text] [Related]
15. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
16. Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase.
Terevnikov V; Stenberg JH; Tiihonen J; Joffe M; Burkin M; Tchoukhine E; Joffe G
Hum Psychopharmacol; 2011 Apr; 26(3):188-93. PubMed ID: 21469215
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN
J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
[TBL] [Abstract][Full Text] [Related]
19. Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study.
Poyurovsky M; Shardorodsky M; Fuchs C; Schneidman M; Weizman A
Br J Psychiatry; 1999 Mar; 174():238-42. PubMed ID: 10448449
[TBL] [Abstract][Full Text] [Related]
20. Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Fischel T; Hermesh H; Aizenberg D; Zemishlany Z; Munitz H; Benjamini Y; Weizman A
J Clin Psychopharmacol; 2001 Dec; 21(6):612-5. PubMed ID: 11763011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
